Cyclobenzaprine PCD Pharma Franchise Company

Cafoli Lifecare offers a Cyclobenzaprine range of 2 tablet formulations, manufactured in WHO-GMP certified facilities. Distributors serving orthopaedic and pain-management prescribers can secure district-wise monopoly franchise rights for this centrally acting muscle relaxant with full promotional support.

What is Cyclobenzaprine?

Cyclobenzaprine is a centrally acting skeletal muscle relaxant, structurally related to the tricyclics. It relieves muscle spasm of local origin by acting on the brainstem rather than directly on muscle, and is used as a short-term adjunct to rest and physiotherapy for painful musculoskeletal conditions. Reference: PubChem - Cyclobenzaprine.

Available Forms

The Cafoli Cyclobenzaprine portfolio is offered as oral Tablets in the commonly prescribed strengths, including combinations for musculoskeletal pain. Contact us for current pack presentations and combinations.

Therapeutic Applications

Cyclobenzaprine is prescribed for the short-term relief of muscle spasm associated with acute painful musculoskeletal conditions such as low-back pain, neck pain, fibromyalgia and sprains. Prescribers include orthopaedic surgeons, physicians, pain specialists and rheumatologists.

Why Cyclobenzaprine is a High-Potential Molecule for Distributors

Back and neck pain and muscle spasm are among the most common complaints in orthopaedic and general practice, and centrally acting muscle relaxants are routinely added to analgesic regimens for them. Cyclobenzaprine offers a differentiated muscle-relaxant option beyond the usual molecules, giving distributors steady add-on volume across the large musculoskeletal-pain segment.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Cyclobenzaprine
2. MedlinePlus: Cyclobenzaprine
3. PubMed: cyclobenzaprine in muscle spasm